Immunomodulatory effect of Î²-glucan on peritoneal macrophages of Babl/c mice by Roudbary, M. et al.
Polish Journal of Microbiology
2015,  Vol. 64,  No 2,  175–179
SHORT COMMUNICATION
* Corresponding author: Sh. Roudbarmohammadi, Department of Mycology, Faculty of Medical Science, Tarbiat Modares University, 
Tehran, Iran; e-mail: Sh.mohammadi@modares.ac.ir
One of the most promising alternatives to classical 
antibiotic treatment is the use of immunomodulators 
for enhancing host defense responses (Nemunaitis, 
1997). Several types of immunomodulators have been 
identified, including mammalian mediators such as 
interferon-gamma (IFN-γ), granulocyte colony-stimu-
lating factor (Hamilten and Anderson, 2004) and gra-
nulocyte macrophage colony-stimulating factor (GM-
CSF) (Plaulsen, 2001), as well as the substances isola- 
ted and purified from microorganisms (Nemunaitis, 
1997). Recently, polysaccharides isolated from botani-
cal sources (mushrooms, algae, lichens and higher 
plants) (Wasser, 2002) have also attracted a great deal 
of attention in the biomedical arena because of their 
broad spectrum of therapeutic properties and their 
relatively low toxicity (Chihara, 1992). Several major 
substances with immunomodulatory and/or antitumor 
activity such as β-D-glucans, polysaccharopeptides 
(PSP), polysaccharide proteins and proteins have been 
isolated from mushrooms (Cristina et al., 2005). 
β-Glucan is a major structural component of fungi and 
it has reported that fungi have a β-Glucan rich cell wall 
compromised of glucose residues arranged in β (1–3) 
D glucopyranosyl polymers with β (1–6) D glucopyra-
nosyl side chains of varying length and frequency dis-
tribution that can activate macrophage for release 
inflammatory agent (Lebron et al., 2003). These extracts 
exert their biological effect through different mecha-
nisms. One of the active compounds responsible for the 
immunomodulatory effects of natural products is in the 
form of complex polysaccharides known as β-Glucans 
(Chang et al., 2009). Indeed, some the basic mecha-
nisms of the immunostimulatory, anti-tumor, bacteri-
cidal and other therapeutic effects of botanical polysac-
charides is thought to occur via macrophage stimulation 
(Wang et al., 1997) and modulation of the complement 
system (Beutler, 2004). Macrophages represent the first 
line of host defense. In addition, macrophages can func-
tion as antigen-presenting cells and interact with T 
lymphocytes to modulate the adaptive immune 
responses (Lingen, 2001). Furthermore, macrophages 
are involved in tissue remodeling during embryogen-
esis, wound repair (Klimp et al., 2002), clearance of 
apoptotic cells and hematopoiesis (Gruchalla and Jones, 
2005). Activated macrophages play a critical role in 
infections by eliminating microbial pathogens through 
the generation of nitric oxide (NO) (Fang and Vazquez-
Torres, 2002). NO as a critical effector molecule of mac-
rophages can be released upon stimulation of mac-
rophages with a  variety of stimuli such as bacterial 
Immunomodulatory Effect of β-Glucan on Peritoneal Macrophages
of Babl/c Mice
MARYAM ROUDBARY1, SAEED DANESHMANDI2, MONIRE HAJIMORADI2,
SHAHLA ROUDBARMOHAMMADI3* and ZUHAIR M. HASSAN2
1 Department of Mycology and Parasitology, School of Medicine, Iran university of Medical Science, Tehran, Iran 
2 Department of Immunology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
3 Department of Mycology, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran
Submitted 4 November 2011, revised 29 November 2014, accepted 15 April 2015
A b s t r a c t
We assessed the effect of β-Glucan on macrophages by Griess reagent and viability by MTT assay and cytotoxicity. Assay of macrophages 
culture supernatants were carried out on WEHI-164 fibrosarcoma cell line as tumor necrosis factor-α bioassay were done. NO release was 
increased at the dose of 10 μg/ml (P = 0.001) of β-Glucan while the viability of macrophages in all concentrations was the same. In TNF-α 
bioassay, the supernatant of macrophages stimulated with β-Glucan had a significant cytotoxic effect on WEHI-164 cells (P = 0.023). 
β-Glucan had a positive effect on increasing tumoricidal activity of macrophages which may help in anti-cancer immune responses.
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products or cytokines. TNF-α also is a main cytokine 
of macrophages with defined activities (Lorsbach and 
Russel, 1992). In the present study, we evaluated the 
immunomodulatory effects of β-Glucan on peritoneal 
macrophages as NO production and cytotoxic effect of 
β-Glucan on cancer cell line with emphasis on coordi-
nate macrophage effect on tumor cells and its function 
as TNF-α bioassay. With this background, β-Glucan 
was purchased from Sigma as a powder that was puri-
fied from Saccharomycess servisiae. In this study, we 
prepared different concentrations of β-Glucan by dis-
solving the powder in distilled water and these were 
used in our study. Female inbred BALB/c mice (at 8 to 
10 weeks of age) were obtained from Pasteur Institute 
(Tehran, Iran). All mice were maintained in a specific 
pathogen-free animal facility at Tarbiat Modares Uni-
versity sterilized water and autoclaved standard mouse 
pellet throughout the study. The animal study was 
approved by a local ethics committee. Peritoneal exu-
dates macrophages were harvested by peritoneal lavage 
from 5 mice by i.p. injection of 10 ml sterile ice cold 
RPMI-1640 (Sigma Chemical Co). The pooled cells 
were centrifuged at 200 × g, washed with PBS (pH = 7.2) 
and resuspended in complete RPMI-1640 supple-
mented with 10% fetal bovine serum (FBS), 2 mM glu-
tamine, 100 u/Penicillin and 100 μg/ml streptomycin 
and 3 × 105 cells/well were added onto 96-well flat-bot-
tomed plates (Nunc) followed by incubation at 37°C for 
4 h under humidified 5% CO2 atmosphere. The non-
adhering cells were then removed by washing the wells 
three times with PBS. The adherent cells were incubated 
for desired time cultured in complete RPMI medium 
and different concentration of β-Glucan (1, 10, 100, 
200 μg/ml) was added to macrophage culture as tripli-
cate wells with the final volume of 200 µl/well. Unstimu-
lated macrophages and also macrophages stimulated 
with 50 IU/ml IFN-γ were considered as negative and 
positive controls, respectively (Ribeiro-Dias et al., 
1998). The cultured cells were incubated at 37°C for 
48 h under humidified 5% CO2 atmosphere. Superna-
tant fluids from macrophage cultures were collected at 
the end of incubation time and stored at –20°C for fur-
ther assays. For MTT assay Macrophage viability was 
evaluated by the MTT (3-(4, 5-dimethylthiazol-2yl)-
2,5-diphenyltetrazolium bromide) (Sigma) assay. After 
48 h of macrophage culture, 20 μl of MTT (5 mg/ml in 
PBS) was added to wells and the plates were incubated 
for 4 h. Formazan crystals developed from MTT reduc-
tion by living cells. The supernatants were then gently 
removed, 100 μl of isopropanol in 0.04% HCl (Sigma, 
USA) was added in order to dissolve the formazan crys-
tals. The plates were incubated overnight and the 
absorbance of each well was measured by ELISA reader 
(Multiskan MS, England) at wavelength of 540 nm 
(Ribeiro-Dias et al., 1998). Stimulation Index (SI) was 
determined as: Absorbance at 540 nm of Test /absorb-
ance at 540 nm of Control. In case of Measurement of 
Nitrite Concentration; NO released into the superna-
tants of cultured macrophages. NO is unstable and rap-
idly converts to nitrite and nitrate. Accordingly, we 
estimated the level of NO synthesis by macrophages via 
measuring the amount of nitrite accumulating in the 
cultures, using the method of Stuehr and Nathan 
(1989). Briefly, nitrite concentration was determined 
with the standard Griess reaction, by adding 50 μl of 
test solution (supernatants of macrophage culture) to 
96-well flat-bottomed plates containing 50 μl of Griess 
reagent [1% sulfanilamide/0.1% N-(1-naphthyl) ethyl-
enediamine dihydrochloride/2.5% H3PO4] (Merck). 
The samples were assessed in triplicate. After 15 min at 
room temperature, the absorbance of each well was 
measured using a ELISA reader (Multiskan MS, Eng-
land) microplate reader at 540 nm and the nitrite con-
centration was determined from a  standard curve 
of sodium nitrite (Stuehr and Nathan, 1989). Mean of 
nitrite concentration (μM) was expressed. For TNF-α 
bioassay; Effect of β-Glucan on tumoricidal activity of 
macrophages in cell-free specimens of each macrophage 
culture was determined by means of the viability of 
WEHI 164 mouse fibrosarcoma cell line through MTT 
assay (Arora et al., 2005). Briefly, macrophages treated 
with β-Glucan (1, 10, 100 and 200 µg/ml) for 48 h and 
the supernatant was stored. Then WEHI 164 target cells 
(2 × 104  cells in 50 μl) cultured in 96-well microtiter 
plate together with 50 μl of stored culture fluid of 
treated macrophages treated with β-Glucan (1, 10, 100 
and 200 µg/ml). WEHI cultures were incubated for 20 h 
at 37°C and 5% CO2 in a humidified incubator. After 
this time, 10 μl of MTT (5 mg/ml in PBS) was added to 
each well and incubated for a further 4 h. Then, super-
natants were removed from each well and replaced with 
100 μl of 0.04 N HCl in isopropanol. The plates were 
then stored overnight in the dark at room temperature. 
After dissolving the dark blue formazan, the optical 
density of each well was measured with an ELISA 
reader (Multiskan MS, England), using the wavelength 
of 540 nm. The percentage of target cells death was cal-
culated as Suppression Index (SuI) as: Absorbance at 
540 nm of Test /absorbance at 540 nm of Control 
(Espevik and Nissen-Meyer, 1987). After test were done 
for Statistical analysis; the cells were harvested from 
5 mice and assays were done as triplicate manner. Data 
was expressed as mean ± SD. The results of MTT test 
were analyzed, using One-Way Analysis of Variance 
(ANOVA) followed by Tukey tests, and a value of 
P < 0.05 were used as the significance levels. After pre-
paration of different concentrations of β-Glucan with 
dissolving in distilled water doses of 1, 10, 100 and 
200 μg/ml of β-Glucan were added to each well of 
microplate containing macrophage cultures in complete 
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medium. NO amount was evaluated in the collected 
supernatants of culture. As shown in Fig. 1, NO produc-
tion was significantly increased (P = 0.0017) at the dose 
of 10 μg/ml compared to the negative control (only 
macrophages). Results of MTT assay indicated that 
viability of macrophages in all concentration of Glucan 
was the same as untreated macrophages (P > 0.05). For 
evaluate the cytotoxic effect of the supernatant of 
macro phages stimulated by β-Glucan on the tumor cell 
line WEHI-164 murine fibrosarcoma as TNF-α bio-
assay, colorimetric MTT cytotoxicity assay was done. 
The results (Fig. 2) indicated that the supernatant of 
treated macrophage contained cytotoxic activity in all 
examined doses (P < 0.05). These effects were declared 
by reduced Suppression Index in β-Glucan-treated 
group compared to negative control. Cytotoxic effect in 
IFN-γ positive control group also was significant 
(P < 0.05). For description of the findings; Glucans are 
a heterogeneous group of glucose polymers with natu-
rally polysaccharides component consisting of a back-
bone of β(1,3)-linked β-D-glucopyranosyl units with 
β(1,6)-linked side chains of varying distribution and 
length that are produced by a variety of plants, such as 
oat, barley, and fungi (Lebron et al., 2003). β-Glucans 
are the constituents of the cell wall of certain patho-
genic bacteria and fungi. The main components of the 
Fig. 1. Effect of β-Glucan on NO release and macrophages viability
Isolated peritoneal macrophages from BALB/c mice were incubated in the absence or presence of β-Glucan for 48 h. The cell supernatants were col-
lected and nitrite production was evaluated. NO production by macrophages was increased at the dose of 10 μg/ml (p = 0.0017) compared to controls. 
MTT reduction ability of macrophages, as a criteria of cell viability for all concentration of β-Glucan was the same as control (p > 0.05). MQ: Macro-
phages, IFN: Interferon-gamma. Data represent mean ± S.D
Fig. 2. Mean ±SD of Suppression Index (SuI) for cytotoxic effect of macrophage supernatant on WEHI-164 fibrosarcoma cells
WEHI-164 cells death was calculated as Suppression Index (SuI) as: Absorbance at 540 nm of Test /absorbance at 540 nm of Control.
Increase of Supernatant TNF-α results in decreased amount of SuI. All concentrations of 1, 10, 100 and 200 μg/ml of β-Glucan significantly
(P = 0.023) increased the ability of macrophage supernatants to kill the cancer cell line
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fungal cell wall are polysaccharides and glycoproteins. 
β-Glucan has been purified from brewer’s and backer’s 
yeast (Tokunakak et al., 2000), from oats and barley 
bran (Baursk and Geisler., 1996). The healing and 
immunostimulatory properties of β-Glucan have been 
suggested for years. β-Glucan may be a powerful 
immune stimulant and be a beneficial antagonist to 
both benign and malignant tumors (Chang et al., 2009). 
Glucans are thought to mediate their effects via interac-
tion with membrane receptors on macrophages, neu-
trophils and NK cells. Macrophages play a critical role 
in all phases of host defense that are both innate and 
adaptive immune responses in case of an infection. 
macrophage can produce cytokine and inflammatory 
mediators such as nitric oxide, NO, and hydrogen per-
oxide, H2O2. Thus activation of macrophage functions 
by β-Glucans increases host immune responses. Some 
previous studies evaluated the effects of β-Glucan on 
macrophages in vitro and in the present study, we eval-
uated in vitro effects of β-Glucan on macrophage func-
tions as NO release as a marker of inflammatory 
responses and anti-cancer potential of macrophage cells 
as a major component of the anti tumor immune 
responses. Our results showed that β-Glucan in all 
examined concentrations had no cytotoxic effect on 
macrophages and imply probable use of β-Glucan 
without toxic effects on the cells. β-Glucan at dose of 
10 μg/ml significantly increased the NO production 
by peritoneal macrophages. A number of studies have 
indicated that polysaccharides stimulate NO but not in 
reactive oxygen intermediate production in a dose-
dependent manner from peritoneum macrophages 
(Ohno et al., 1996). Therefore, β-Glucan has a direct 
anti-cancer effect (Chang et al., 2009) and can inhibit 
tumor development as well as reducing its proliferation. 
(Akramiene et al., 2007). In order to evaluate the anti-
tumor properties of Glucan, macrophage culture super-
natants were affected on WEHI-164 fibrosarcoma cells. 
WEHI-164 cells are susceptible to the release of TNF-α 
from macrophages (Arora et al., 2005). The results indi-
cated that in all examined concentrations, tumoricidal 
TNF-α bioactivity which was compatible with IFN-γ 
positive control was enhanced. Increased cytotoxicity 
of macrophage supernatant culture on WEHI fibrosar-
coma cell line suggests that β-Glucan could elevate the 
tumoricidal activity of macrophages as one of its indi-
rect anti tumor activities. Moreover, fungal cell wall 
component has been found to be a major element in 
the activation of macrophages and the production of 
inflammatory mediators from these cells. (Chan et al., 
2009; Fernandesda et al., 2010). These results indicate 
that β-Glucan could enhance proinflammatory agents 
production from macrophages and also increase the 
tumoricidal activity of macrophages on tumor cell line. 
These results are coordinate with other investigations 
which have disclosed inhibitory effect of β-Glucan on 
tumor growth. In addition, the findings proved that 
β-Glucan increased the number of peritoneal mac-
rophages receptors in molecular host-mediated mecha-
nisms (Ukaway et al., 2000). Natural components regu-
late macrophages functions. In particular, these 
compounds have been shown to increase macrophage 
cytotoxic activity against tumor cells and microorgan-
isms, activate phagocytic activity, increase reactive oxy-
gen species (ROS) and nitric oxide (NO) production 
and to enhance the secretion of cytokines and 
chemokines, such as tumor necrosis factor (TNF-α), 
interleukin (IL)-1, IL-6, IL-8, IL-12, IFN-γ (Brummer 
et al., 2007). The resulting antitumor effect of β-Glucan 
could be due to each of these mechanisms or a combi-
nation of several mechanisms. The discovery and iden-
tification of new and safe drugs without adverse side 
effects, is the ultimate goal of research in the biomedical 
science. Medicinal applications have been demon-
strated for many traditionally used mushrooms, with 
large differences in immunomodulatory properties. The 
species studied so far represent a vast source of immu-
nomodulating and anti tumor extracts and metabolite 
(Cristina et al., 2005) . Finally, the results of the present 
study indicate that β-Glucan could enhance NO pro-
duction from macrophages and increase the tumori-
cidal activity of macrophages on WEHI-164 fibrosar-
coma cells. The results point to β-Glucan as a natural 
immunostimulatory agent with tumoricidal activity 
as well as its application in the treatment of cancer. 
Further studies are needed to clarify the advantages of 
this component in clinical applications.
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